
- /
- Supported exchanges
- / US
- / CLPT.NASDAQ
Clearpoint Neuro Inc (CLPT NASDAQ) stock market data APIs
Clearpoint Neuro Inc Financial Data Overview
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Clearpoint Neuro Inc data using free add-ons & libraries
Get Clearpoint Neuro Inc Fundamental Data
Clearpoint Neuro Inc Fundamental data includes:
- Net Revenue: 32 236 K
- EBITDA: -20 853 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-05
- EPS/Forecast: -0.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Clearpoint Neuro Inc News

ClearPoint Neuro May 2025 presentation: Enters 'Fast Forward' phase after Q1 revenue beat
Introduction & Market Context ClearPoint Neuro Inc. (NASDAQ:CLPT) unveiled its corporate presentation on May 13, 2025, highlighting the company’s strategic vision as it enters what management calls...


ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
We came across a bullish thesis on ClearPoint Neuro, Inc. (CLPT) on M.V. Cunha’s Substack. In this article, we will summarize the bulls’ thesis on CLPT. ClearPoint Neuro, Inc. (CLPT)'s share was t...

Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint
After uniQure (QURE) provided a regulatory update on AMT-130, its investigational gene therapy for the treatment of Huntington’s disease, and said the company has reached alignment with the FDA to s...

The 3 Best Brain-Computer Interface Stocks to Buy Now
Brain-computer interface (BCI) technology creates a direct link between the brain’s electrical activity and a digital device. This connection can bring a vast range of benefits in assisting, augment...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.